Changeflow GovPing Government General AngioDynamics Soft-Vu Angiographic Catheter Rec...
Urgent Enforcement Amended Final

AngioDynamics Soft-Vu Angiographic Catheter Recall - Guidewire Passage Defect

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

FDA Class II recall initiated March 3, 2026 for AngioDynamics Soft-Vu Angiographic Catheters (Catalog No. 10714001) due to a manufacturing defect that may prevent the appropriately sized guidewire from passing through the catheter hub inner diameter. The recall affects 1550 units across five lots distributed worldwide including the US, Canada, European countries, and others. Urgent voluntary recall letters were sent to customers instructing immediate cessation of use and product return.

“The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.”

FDA , verbatim from source
Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

AngioDynamics initiated a Class II voluntary medical device recall for its Soft-Vu Angiographic Catheters on March 3, 2026, after identifying a manufacturing defect in the catheter hub inner diameter that may prevent guidewire passage. FDA determined the cause is nonconforming material or component. Five lot numbers are affected: A2425078, A3325036, A3525030, A3525031, and A3725102, totaling 1550 units distributed worldwide.

Healthcare facilities and distributors holding these catheters should immediately cease use, segregate affected inventory, and arrange return to AngioDynamics. The recall applies to any facility using these catheters in interventional radiology or vascular procedures where guidewire passage through the catheter hub is required. Facilities should also notify all clinical staff and satellite locations that received the affected product.

What to do next

  1. Stop using the devices subject to this recall and share the notification to all users of the devices within your facility immediately.
  2. Provide a copy of this recall notification to all sites or clinics to which you have distributed affected product.
  3. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping and Receiving or ANY other location).
  4. Segregate this product in a secure location for return to AngioDynamics, Inc.
  5. Package and Return the Recalled Product.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall Angiodynamics SoftVu

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall Angiodynamics SoftVu | |

Date Initiated by Firm March 03, 2026
Date Posted April 17, 2026
Recall Status Open , Classified
Recall Number Z-1858-2026
Recall Event ID 98463
510(K)Number K112452 K161596 K173762
Product Classification Catheter, intravascular, diagnostic - Product Code DQO
Product Soft-Vu Angiographic Catheter, Omni Flush, Non-Braided;

SOFT-VU OF 4F X 65CM 038 NB 6SH;
Catalog No.: 10714001;
Product/UPN No.: H787107140015 (Box), H787107140010 (Pouch);
Box Quantity: 10 pouches; |
| Code Information | SOFT-VU OF 4F X 65CM 038 NB 6SH;
Catalog No.: 10714001;
Product/UPN No.: H787107140015 (Box), H787107140010 (Pouch);
UDI-DI: 25051684007778(Box), 15051684007771(Pouch);
Lot No.: A2425078, A3325036, A3525030, A3525031, A3725102; |
| FEI Number | 1319211 |
| Recalling Firm/
Manufacturer | Angiodynamics, Inc.
603 Queensbury Ave
Queensbury NY 12804-7619 |
| For Additional Information Contact | Kasey Newcomb
978-333-1108 |
| Manufacturer Reason
for Recall | The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub. |
| FDA Determined
Cause | Nonconforming Material/Component |
| Action | On March 3, 2026 URGENT VOLUNTARY MEDICAL DEVICE RECALL letters were sent to customers.
Actions to be taken:
IMMEDIATELY:
1. Stop using the devices subject to this recall and share the notification to all users of the deviceswithin your facility immediately.
2. Provide a copy of this recall notification to all sites or clinics to which you have distributed affectedproduct.
3. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping andReceiving or ANY other location).
4. Segregate this product in a secure location for return to AngioDynamics, Inc.
5. Package and Return the Recalled Product. |
| Quantity in Commerce | 1550 units (155 boxes) |
| Distribution | Worldwide distribution - US Nationwide and the countries of Austria, Australia, Belgium, Canada, China, Chile, Curacao, Czech Republic, Germany, Ireland, Israel, Italy, Lebanon, Netherlands, New Zealand, Panama, Slovenia, South Africa, Spain, Sweden, Thailand. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

| 510(K) Database | 510(K)s with Product Code = DQO |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 3rd, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Product recall response Medical device distribution
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!